ENTITY
WuXi AppTec

WuXi AppTec (603259 CH)

244
Analysis
Health CareChina
WuXi AppTec Co., Ltd. manufactures medical products. The Company produces biological agents, antibodies, biological diagnostic reagents, and other products. WuXi AppTec also provides biological analysis, technical study, and other services.
more
Refresh
03 May 2020 17:18

SH/​SZ Connect Flow Weekly: Active Flows for Vaccine Stocks

In our weekly Shanghai/Shenzhen Connect Ideas series, we aim to highlight key stocks and sectors which the mainland investors traded via the...

Logo
214 Views
Share
26 Apr 2020 20:49

Tigermed IPO Initiation: Trade-Offs

Hangzhou Tigermed Consulting (300347 CH) is a global contract research organisation (CRO). Tigermed is the largest clinical CRO in China with a...

Logo
410 Views
Share
26 Apr 2020 14:29

Tigermed (泰格医疗) A+H Listing: Hot Deal of the Best China Clinical-CRO Play

Hangzhou Tigermed is a leading China-based CRO company seeking a USD 1 bn H-share listing in Hong Kong. The company was listed on the A-share...

Logo
472 Views
Share
31 Mar 2020 10:03

SH/SZ Connect Flows: Wuxi Apptec, ZTE, Yili

In our weekly Shanghai/Shenzhen Connect Ideas series, we aim to help our investors understand the flow of northbound trades via the Shanghai and...

Logo
252 Views
Share
29 Mar 2020 12:18

ECM Weekly (29 Mar 2020) - Wuxi AppTec, Kintor Pharma, Softbank Group-Driven Placements and More!

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. We...

Share
x